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Objective: As a result of the use of neuroimaging techniques, silent pituitary le-
sions are diagnosed more and more frequently; however, there are few published 
post-mortem studies about this gland. Incidence data of pituitary lesions are rare 
and in Portugal they are outdated or even non-existent. The aim of this study is 
to determine the prevalence of normal patterns and incidental post-mortem pi-
tuitary pathology at Centro Hospitalar Lisboa Norte, analyzing the associations 
with clinical data and assessing the clinical relevance of the findings. 
Method: We reviewed retrospectively and histologically 167 pituitaries of a con-
secutive series of autopsies from the Department of Pathology of this centre. 
They were done between 2012 and 2014, and in all cases medical records were 
reviewed. The morphological patterns observed, were classified into three major 
groups: 1) Normal histological patterns and variants; 2) Infectious-inflamma-
tory pathology, metabolic and vascular disorders; 3) Incidental primary prolif-
eration and secondary to systemic diseases. 
Results: The subjects included in this study were of all age groups (from 1 day 
to 91 years old), 71 were female and 96 male. Fifty-seven of these glands didn’t 
show any alteration; 51 showed colloid cysts arising from Rathke cleft; 44 pre-
sented hyperplasia in adenohypophysis and we identified 20 adenomas in 19 
glands (immunohistochemically, eight PRL-producing and five ACTH-produc-
ing tumors), ten of which associated with obesity, 11 to hypertension and six to 
diabetes mellitus. There were two cases with metastasis. 
Conclusion: Subclinical pathology in our country is similar to that seen in oth-
er parts of the world, but at older ages.
Keywords: pathology, pituitary gland, autopsy.
introduction
Studies on the incidence and prevalence of pituitary ad-
enomas (PA) and related injuries have varied over time 
and depending on the population studied. These varia-
tions are related to advances in health including increased 
access to modern imaging studies and the increased num-
ber of specialists in endocrinology. As a result of the de-
velopment and widespread use of neuroradiology imag-
ing studies, namely computed tomography (CT) and 
magnetic resonance imaging (MRI), silent pituitary le-
sions are diagnosed increasingly often.1-3 In a recent re-
view of autopsy and MRI studies, the estimated global 
prevalence of PA was 16.7%.4 Recently it has been recog-
nized that the prevalence of clinically diagnosed PA is 3.5 
to 5 times more common than previously thought, ac-
cording to a Belgian study that showed a prevalence of 
approximately 1 per 1,000 persons.5
The management of pituitary pathology is complex 
and requires the recognition of many pathological enti-
ties. In autopsy series, the incidence of pituitary pathol-
ogy lies between 3 and 27%.6 Variants within normality 
and pituitary changes that do not lead to relevant clin-
ical translation were described. In addition, there are pi-
tuitary lesions (hyperplasia, microadenomas, pituitary 
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atrophy, etc.) that may go unnoticed for long periods of 
time or even fail to be diagnosed due to their limited 
clinical significance. The incidental discovery of PA has 
become a subject of growing interest. However, the fre-
quency with which systemic diseases (granulomatous 
inflammation, metabolic processes, metastatic tumors, 
etc.) can affect secondarily the structure of this gland is 
not known.2,7,8
Data on incidence of PA in the population are scarce, 
and the series based on MRI and autopsies are discordant 
with the surgical series in tertiary centers. Since the prev-
alence of values in different ethnic groups or populations 
is unclear, further studies are needed community-based, 
defining the real burden of pituitary lesions in the usual 
clinical practice, as well as geographical differences.
In Portugal, data on pituitary disease are scarce, ob-
solete or non-existent, which means that the national 
health system lacks reliable and updated epidemiologi-
cal data to ensure adequate resource allocation, propor-
tional to the impact of such tumors in the community.
Most post-mortem studies were done in forensic au-
topsies and many of them recommended, due to the high 
frequency of occult pituitary lesions found, anatomical 
and clinical autopsy studies in order to evaluate the as-
sociated clinical features.9
The objective of this study is to determine the prev-
alence of normal patterns and incidental post-mortem 
pituitary pathology in a consecutive series of patients 
of Centro Hospitalar Lisboa Norte (CHLN) – the larg-
est referral center in Portugal –, which includes Hospi-
tal Santa Maria and Hospital Pulido Valente in Lisbon, 
analyzing possible associations with the available clin-
ical data and highlighting the medical relevance of the 
findings.
Method
For the preparation of this work, 167 pituitary glands of 
a consecutive series of autopsies conducted by the Path-
ological Anatomy Service of CHLN were studied retro-
spectively. Autopsies were conducted between 1/1/12 and 
12/31/14. Pediatric necropsies (newborns and children) 
were included.
In all cases examined, the corresponding medical re-
cords were reviewed, with analysis of the following vari-
ables: age, gender, reason for inclusion, personal medical 
history and causes of death, including in the case of neo-
natal autopsies, the study of the placenta.
During the autopsy, the pituitary stalk was cut as 
high as possible to leave the gland intact. The procedure 
involved opening the sellar diaphragm and fracturing the 
dorsum of the sella turcica, subsequently pushed to al-
low the gland to be removed intact. Immediately after ex-
traction, the pituitary glands were fixed in 10% buffered 
formaldehyde for at least 24 hours and up to 72 hours. 
Subsequently, the glands were assessed macroscopically, 
weighed, measured, cut sagittally, and processed accord-
ing to the usual technical procedures for fixing in paraf-
fin blocks for a complete histological evaluation. Sections 
were cut at 2 micra for hematoxylin-eosin (H&E) stain-
ing, 4 micra for reticulin staining (Gomori’s method), and 
2 micra for immunohistochemical study, if necessary. In 
the latter case, the glands were deparaffinized, subjected 
to antigen retrieval and incubated with individual anti-
bodies directed against specific pituitary hormones or 
cellular proteins (Table 1).
TABLE 1 Antibodies used, origin, dilution and clone.
Antibody against Origin Dilution Clone
PRL Dako 1:300 Polyclonal
GH Dako 1:400 Polyclonal
ACTH Dako 1:100 O2A3
FSH Novocastra 1:25 INN-HFSH-60
Subunit-alpha Novocastra 1:200 4E12
TSH Serotec 1:50 AHP523
Ki-67 Dako 1:150 MIB-1
p53 Novocastra 1:70 D07
PRL: prolactin; GH: growth hormone; ACTH: adrenocorticotropic hormone; FSH: follicle-sti-
mulating hormone; TSH: thyroid-stimulating hormone.
The preparations were stained with H&E and reticulin, 
as well as pituitary hormones (PRL, GH, ACTH, FSH, sub-
unit-alpha, and TSH) or Ki-67 (indicative of cell prolifer-
ation) and p53 (tumor suppressor gene) where necessary. 
PAs found were sorted according to the 2004 version of 
the World Health Organization (WHO) classification of 
tumors of endocrine organs.10
Cases in which necropsy was partial and limited to 
the thoracic and/or abdominal cavity; cases in which the 
time elapsed from death to completion of the examina-
tion was over 24 hours; and those cases in which the corpse 
was in poor conditions, and the glands showed evidence 
of autolysis were not included in this study.
We defined as pituitary incidentalomas all unexpect-
ed pituitary sellar lesions found during the necropsy due 
to any unrelated reason. This definition excludes subjects 
who experienced symptoms described as typical for PA, 
including visual changes and syndromes of defective or 
excessive pituitary hormone secretion.
Based on the findings, since the differential diagno-
sis of presumably asymptomatic lesions is quite broad, 
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the observed morphological patterns were classified into 
three groups:
1. Histologically normal patterns and variants (develo-
pmental anomalies and cystic lesions);
2. Infectious-inflammatory disease, metabolic disorders 
and vascular disorders;
3. Incidental primary proliferation and secondary to 
systemic diseases.
results
Gender distribution was 71 (42.5%) females and 96 (57.5%) 
males, with 153 corpses of white race and 14 colored. Age 
ranged between 1 day and 91 years; 22.8% of the autop-
sies were conducted on subjects between 70 and 79 years 
old (Chart 1). All autopsies derived from the different Ser-
vices offered at the CHLN.
Histologically normal patterns and variants
Fifty-seven (34.1%) of the glands examined showed no 
histologic abnormalities with possible pathological sig-
nificance, 20 of which (out of 24) accounted for autop-
sies in individuals under 18 years. Considering only adult 
glands (aged between 18 and 65 years), the average weight 
after fixation was 0.74+/-0.25 g, and the average size of 
their longest axis was 13.94+/-1.72 mm.
Fifty-one of the 167 glands studied (30.5%) had col-
loid cysts derived from Rathke’s cleft. In all cases, the cysts 
were located in the intermediate lobe; in two subjects, they 
were also located in the pars tuberalis. These were single 
cysts (in 11 of the glands) or, more frequently, multiple 
(40 cases; 78.4%) small cysts between less than 1 and 9 mm.
Three percent of the glands studied (five cases) had 
inframillimetric foci of squamous metaplasia with glan-
dular remnants. They were observed in groups, mainly in 
the pituitary stalk and, less often, in the pars tuberalis. 
In 23 of the 167 cases (13.8%), rows of basophil en-
docrine cells immunohistochemically positive for ACTH 
were observed extending from the interface of the ante-
rior and posterior lobes to the depth of the neurohypoph-
ysis. All cases were related to individuals older than 50 
years (except for the gland of a 23 years old subject).
Herring bodies were also found in the neurohypoph-
ysis of two males (73 and 82 years old).
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In one gland in this series, we observed a concentric 
arrangement of unmyelinated nerve fibers comprising 
the neurohypophysis, which gave it a nodular appearance 
that reminded schwannomas (“nodular” neurohypoph-
ysis). It measured 1 mm and was located at the interface 
of the pars nervosa up to the infundibulum; there was no 
association with cellular pleomorphism, anisokaryosis, 
mitosis or other changes.
The cells in the neurohypophysis had granular trans-
formation in three subjects, one female and two males, 
aged 62-78 years, one with amyloidosis and two with 
chronic renal failure (CRF).
None of the autopsies performed revealed atrophy or 
flattening of the pituitary gland similar to that described 
in empty sella syndrome (intrasellar arachnoidocele that 
occurs as a result of a change in the diaphragm),11,12 and 
no cases of pan-hypopituitarism was found in the review 
of clinical histories.
None of the findings correlated with clinical symp-
toms that were mentioned in the medical history.
Infectious-inflammatory disease, metabolic disorders and vascular 
disorders
The presence of isolated lymphocytic foci within the ad-
enohypophysis was a finding found in six of 167 autop-
sies (3.6%). In these cases, the subjects were between 61 
and 90 years old (except for a patient aged 39 years), and 
lymphocytes were mature and positioned as isolated cells, 
not causing destruction of the gland. Autoimmune or 
lymphoproliferative diseases were not constant.
There was nonspecific chronic inflammation in two 
newborns whose placentas revealed infection and hypox-
emia, and in a 70-year-old with a history of epilepsy and 
meningitis. There was also an active chronic periglandu-
lar inflammatory infiltrate in a 75-year-old who died due 
to complications of a flu-like illness.
The presence of intracellular deposits of pigment in 
the neurohypophysis was a relatively common finding 
(six of 167 autopsies). They are dispersed in the paren-
chyma and were associated in two cases with cerebrovas-
cular accident (stroke) and hemolysis; in other cases, no 
relationship was found.
We must highlight the incidence of pituitary vascu-
lar disease in this series of clinical autopsies (3%); five of 
the examined glands had ischemic strokes. Age ranged 
between 41 and 82 years. In all cases, the review of the pa-
tients’ medical history showed vascular risk factors such 
as high blood pressure (hypertension), diabetes mellitus 
(DM) or stroke, and more. 
The presence of benign vascular proliferations was 
not observed in any of the 167 cases.
Incidental primary proliferation and secondary to systemic 
diseases
Forty-four of the studied pituitary glands (26.3%) showed 
adenohypophysis hyperplasia, with expansion of the aci-
ni demonstrated by reticulin histochemical staining. In 
some cases there was a focal pattern, and in others a dif-
fuse pattern, involving one or more cell types. Sixteen of 
the affected subjects were women and 28 men. Age ranged 
from 23 to 91 years. Considering only the glands of adults 
(aged 18 to 65 years), the mean size after fixation was 
14.69+/-2.02 mm, which implies a slight increase with re-
spect to the average normal pituitary.
Since we did not find in the clinical histories of pa-
tients whose pituitary glands had hyperplasia any data 
that could be related to etiology, these cases were con-
sidered as asymptomatic or incidental idiopathic hyper-
plasia.
Twenty “typical” PAs were found in 19 subjects (one 
gland with two tumors), all smaller than 10 mm (mi-
croadenomas). Nine subjects were female (12.7% of the 
total cases in females) and 11 male (11.5% of the total 
males). Age ranged from 10 to 88 years, with 14 cases 
(70%) between the 7th and 9th decades of life. Immuno-
histochemically, four were PRL-producing tumors, two 
PRL/GH, one PRL/GH/FSH, one PRL/GH/TSH, one 
GH/TSH, five ACTH (one of which with pituitary apo-
plexy), one FSH, three plurihormonal tumors, and two 
null-cell. Clinically, 10 cases were associated with obe-
sity (one morbid), 11 HBP and six DM; there were no 
cases associated with hypo- or hyperthyroidism. Atyp-
ical cases of PA or primary pituitary carcinomas were 
not identified.
The PAs were not large enough to produce clinical 
symptoms. After the clinical histories were reviewed, none 
of the patients with lesions described had information 
pointing to compressive, visual or endocrine symptoms 
that could be related to the pathologic findings.
Of 25 autopsies with malignancies in various organs 
and tissues (two lung, two kidney, three bladder, two pros-
tate, four colon, two sarcomas, one oligodendroglioma, 
two lymphocytic lymphoma/chronic lymphocytic leuke-
mia – LL/CLL –, one multiple myeloma – MM –, one in-
travascular lymphoma, one myeloblastic leukemia, and 
four tumors of unknown origin), two cases presented 
metastatic infiltration of the pituitary gland (one LL/CLL 
and one small cell lung carcinoma).
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discussion
Keep in mind that the collection of data from the 167 
subjects was retrospective, and clinicopathological cor-
relation is based on data previously collected on clinical 
history. Thus, it is possible that this was not an accurate 
and comprehensive reflection of the patient’s situation, 
or that the pituitary disease generated symptoms that 
were not so relevant within the context of morbidity, which 
implies a limitation to this study.
We must also consider that the sample size does not 
allow for statistical significance necessary to some of the 
findings, and that we can only assume the trends. Never-
theless, interest is still great since these data derive from 
a series of anatomical and clinical autopsies.
Since the pediatric population is included, as well as a 
wide range of subjects of different age groups, we consider 
this a representative sample of the general population.
Within the patterns of histological normality and vari-
ants, our study showed in normal pituitary glands: col-
loid cysts, foci of squamous metaplasia, rows of endocrine 
cells in the neurohypophysis, Herring bodies, nodular 
transformation of the neurohypophysis and modification 
of its cells, adopting aspect of granular cells similar to 
those observed in other organs.
Colloid cysts are relatively frequent, small and asymp-
tomatic. These remnants of Rathke’s cleft are common 
incidental findings in autopsies. Studies in normal pitu-
itary gland demonstrated that they appear in 32% of cas-
es13 (30.5% in our series); of these, 80% (100% in our se-
ries) were located in the intermediate lobe and the other 
in pars tuberalis. 
Sometimes, the cysts are large enough to produce 
symptoms due to compression of the pituitary gland, op-
tic chiasm and hypothalamus.14 Sometimes the infection 
of a cyst can cause the formation of abscesses.15 These 
cysts are benign and usually heal after they are excised.16 
Subjects who undergo partial excision and drainage may 
have recurrences.
Squamous metaplasia of glandular remains is an adap-
tive process that appears with some frequency (3% in our 
series). Sometimes it leads to the formation of cysts large 
enough to produce symptoms,17 which are primarily visu-
al. Resection is often incomplete since it can affect vital 
structures, but relapse occurs very slowly over the years. 
Malignant transformation to squamous cell carcinoma is 
rare, but can occur.18
The presence of rows of ACTH-immunoreactive ba-
sophil cells in the posterior pituitary (“basophil invasion”) 
is an age-related finding not customarily associated with 
endocrinopathies.
Sometimes it is possible to discern using H&E in the 
neurohypophysis swollen axons that store oxytocin or va-
sopressin, with eosinophilic fibrillar appearance, which 
are called Herring bodies or neurosecretory bodies and 
constitute a normal finding.
Aggregates of polygonal cells with granular cytoplasm 
in the neurohypophysis or infundibulum are incidental 
findings at autopsy.19 They are usually asymptomatic but, 
if they grow, they can compress the gland, the optic chi-
asm or the hypothalamus.
Not often, infectious-inflammatory disease, meta-
bolic disorders and vascular disorders can occur, which 
may affect the primary or secondary structure of this 
gland. In our study, we highlight the presence of isolat-
ed lymphocytic foci, nonspecific inflammation, ferric 
pigment deposits in the posterior pituitary, and some 
ischemic strokes.
Occasionally, a small number of lymphocytes can be 
seen on the interface between the anterior and posterior 
lobes of the pituitary.20 Histologically, the cells are easily 
distinguished from the extensive and destructive infiltra-
tion observed in lymphocytic hypophysitis. Microfoci of 
lymphocytes have no clinical significance. Lymphocytic 
hypophysitis, by contrast, is a well-described inflamma-
tory process,21 which can resemble PAs clinically and ra-
diologically. Approximately 80% of cases occur in preg-
nancy, mostly postpartum, and they are characterized by 
total or partial pituitary insufficiency due to an autoim-
mune process,22 with men affected on rare occasions.
The presence of intracellular deposits of ferric pig-
ment in macrophages of the neurohypophysis (confirmed 
in our series by histochemical study using Perls staining) 
was a relatively common finding (observed in six of 167 
autopsies). These deposits seem to indicate minor bleed-
ing similar to those that occur in other organs during 
small coagulation disorders, hypersideremia or mild lo-
cal trauma.7 We did not find in our study a possible asso-
ciation between some sort of specific pathology and the 
presence of such deposits. Given our sample size, it is dif-
ficult to know whether this is a significant finding or if it 
is caused by chance.
In our study, the five subjects with ischemic infarcts 
also had risk factors (obesity, HBP, DM and/or stroke). 
Age range was wide, between 41 and 82 years, although 
three of these five subjects (60%) were relatively young (41, 
43 and 56 years old). However, it is noted that for clinical 
endocrine symptoms to appear, pituitary destruction 
must be greater than 50%.23
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As for pituitary incidental primary proliferation and 
secondary to systemic diseases, we point out the occur-
rence of hyperplasia, adenomas and metastases.
Although in the past it was believed that the focal 
hyperplasia did not occur in the pituitary gland, cur-
rently there is no doubt that it exists and that it may even 
appear clinically and biochemically.24,25 In this series, ac-
inar hyperplasia was observed in 44 of the 167 pituitary 
glands. The medical history of these subjects did not in-
clude information (either clinical or biochemical) that 
could be connected to the etiology of hyperplasia. While 
hyperplasia is a well-described phenomenon, there are 
still questions that remain without clear answer: Are all 
forms of hyperplasia primary or they result from hypo-
thalamic changes? Are these cellular adaptation process-
es leading to adenomas? Are hyperplastic cells more 
prone to malignant transformation? What are the mo-
lecular mechanisms related to this hyperplasia?26,27 The 
predominance of males (63.6% of cases) in our series 
stands out, contrary to what is classically described for 
adenomas.
PAs comprise 10-20% of all intracranial tumors.4 They 
affect mainly women between the 3rd and 6th decade, but 
can occur in any age group.28,29 Small incidental adeno-
mas can occur with a probability of 20% in pituitary glands 
examined at autopsy.30,31
The incidence of adenomas in this study is consis-
tent with that found in other series. Twenty adenomas 
(12.1%) were found; other studies4,32 show incidences at 
10-20%. Coinciding with the classically described in the 
literature, women were slightly more affected than men. 
In our study series, ages ranged from 30 to 88 years (ex-
cept for a 10 year old child), with 14 cases between the 
7th and 9th decades of life, slightly higher than that found 
in other reviews.1,8,30 The most frequently found adeno-
mas are prolactinomas.30,32,33 In our series, of the 20 PAs 
founds, four were PRL-producing tumors, other four 
cases were PRL/GH, and five corresponded to ACTH-
producing adenomas. If we compare these data with the 
analysis of the surgical series held between 2004 and 
2013 in the same hospital, in which 220 PAs were ana-
lyzed, we observe a prevalence of adenomas positive for 
GH (60) and FSH (59), followed by ACTH-producing tu-
mors (44). Only 24 adenomas were PRL-secreting (a good 
response to medical treatment lead to low prevalence in 
surgical series).
The pathogenesis of apoplexy, an uncommon find-
ing, is also little known. Pituitary apoplexy is defined as 
the sudden manifestation of symptoms such as severe 
headache, nausea, vomiting, loss of vision, paralysis of 
the cranial nerves and altered consciousness with radio-
logic evidence of hemorrhagic stroke in PA.34 Several neu-
rosurgical series indicate that the incidence of pituitary 
apoplexy ranges from 2 to 7% when the clinical signs are 
associated with histopathological evidence of hemor-
rhage or necrosis. All kinds of gland tumors have simi-
lar risk of apoplexy. Men are more affected than women 
(2:1). Randeva et al. conducted a retrospective study of 
cases of pituitary apoplexy in order to establish the clin-
ical presentation, predisposing factors, treatment and 
patient outcome.34 They concluded that the most com-
mon symptom is headache, and that HBP may be an im-
portant predisposing factor. In another similar study, 
also retrospective, carried out by Da Motta et al., the au-
thors concluded that pituitary apoplexy is not an infre-
quent complication of adenomas.35 Only one of the 20 
observed adenomas (ACTH-secreting) presented this 
phenomenon in a 30-year-old man with HBP.
Comparatively, primary tumors of the neurohypoph-
ysis are rare and, in general, similar to primary tumors of 
the central nervous system. This is confirmed in our study, 
which found no cancer in this part of the gland.
Two of the 25 cases of cancer in different organs and 
tissues (8%) had pituitary metastases (one LL/CLL and 
one lung carcinoma). Other series showed similar inci-
dence, between 2 and 25%,36-38 although most metastat-
ic tumors are clinically asymptomatic. It should be not-
ed that breast and lung cancers are the most common 
primary neoplasms leading to metastases in the pitu-
itary.39-43 In this study, there were only two cases of lung 
tumors (one of which metastasized) and no cases of 
breast cancer.
conclusion 
The prevalence of pituitary pathology found in our midst 
in this series of anatomical and clinical autopsy is simi-
lar to that described elsewhere in the world. However, con-
trary to what has been described in the literature, we have 
observed an increase in age at diagnosis. As seen in oth-
er studies, post-mortem pituitary adenomas predomi-
nate slightly among women and strongly differ from those 
found in surgical series regarding types of adenoma.
To our knowledge, this is the first comprehensive and 
updated study to estimate the prevalence of post-mortem 
incidental pituitary pathology conducted in Portugal. 
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resuMo
Características histopatológicas de hipófises post mortem: 
análise retrospectiva 
Objetivo: como resultado da utilização de técnicas de 
neuroimagem, cada vez se diagnosticam mais lesões hi-
pofisárias silentes; porém, há poucos estudos post mortem 
publicados sobre essa glândula. Os dados de incidência 
existentes sobre lesões hipofisárias são raros, sendo em 
Portugal desatualizados ou inexistentes. O objetivo é de-
terminar a prevalência dos padrões normais e da patolo-
gia hipofisária incidental post mortem no Centro Hospita-
lar Lisboa Norte, analisando as associações com dados 
clínicos e avaliando a relevância clínica dos achados. 
Método: revisaram-se histologicamente de forma retros-
pectiva 167 hipófises de uma série consecutiva de autóp-
sias do Serviço de Anatomia Patológica desse centro, rea-
lizadas entre 2012 e 2014, sendo revisadas em todos os 
casos as histórias clínicas. Os padrões morfológicos ob-
servados classificaram-se em três grandes grupos: 1) pa-
drões histológicos de normalidade e variantes; 2) patolo-
gia infeccioso-inflamatória, distúrbios metabólicos e 
transtornos vasculares; 3) proliferação primária inciden-
tal e secundária a doenças sistêmicas. 
Resultados: os doentes incluíam todas as faixas etárias 
(de 1 dia a 91 anos), sendo 71 do sexo feminino e 96 do 
masculino. Cinquenta e sete das glândulas não apresen-
taram qualquer alteração; 51 mostraram cistos coloides 
derivados da fissura de Rathke; em 44, observou-se hiper-
plasia da adeno-hipófise e identificaram-se 20 adenomas 
em 19 glândulas (oito imuno-histoquimicamente produ-
tores de PRL e cinco de ACTH), dos quais dez associados 
à obesidade, 11 à hipertensão arterial e seis a diabetes mel-
litus. Houve dois casos com metástases. 
Conclusão: a patologia subclínica em nosso meio é simi-
lar à observada em outras partes do mundo, mas em ida-
des mais avançadas.
Palavras-chave: patologia, hipófise, autopsia.
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